 Heather Anderson
Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Students, Pharmacy | 2 | 2024 | 96 | 1.230 |
Why?
| | Electronic Health Records | 2 | 2025 | 1202 | 0.730 |
Why?
| | Pharmacogenomic Testing | 1 | 2020 | 63 | 0.600 |
Why?
| | Curriculum | 2 | 2024 | 1074 | 0.580 |
Why?
| | Severity of Illness Index | 2 | 2025 | 2933 | 0.560 |
Why?
| | Benzodiazepines | 1 | 2019 | 168 | 0.550 |
Why?
| | Suicidal Ideation | 2 | 2015 | 583 | 0.500 |
Why?
| | Faculty, Pharmacy | 1 | 2017 | 20 | 0.500 |
Why?
| | Anxiety Disorders | 1 | 2019 | 371 | 0.480 |
Why?
| | Sleep Wake Disorders | 1 | 2019 | 314 | 0.450 |
Why?
| | Guideline Adherence | 1 | 2019 | 587 | 0.440 |
Why?
| | Medicare | 1 | 2020 | 904 | 0.410 |
Why?
| | Antidepressive Agents | 2 | 2015 | 242 | 0.400 |
Why?
| | Research | 1 | 2017 | 431 | 0.390 |
Why?
| | Depression | 2 | 2011 | 1557 | 0.340 |
Why?
| | Nausea | 1 | 2011 | 112 | 0.340 |
Why?
| | Psychomotor Agitation | 1 | 2011 | 69 | 0.340 |
Why?
| | Vomiting | 1 | 2011 | 131 | 0.330 |
Why?
| | Sexual Dysfunction, Physiological | 1 | 2011 | 75 | 0.330 |
Why?
| | Headache | 1 | 2011 | 151 | 0.320 |
Why?
| | Foster Home Care | 1 | 2011 | 88 | 0.300 |
Why?
| | Clinical Competence | 1 | 2017 | 1247 | 0.280 |
Why?
| | Child Welfare | 1 | 2011 | 233 | 0.280 |
Why?
| | United States | 7 | 2024 | 16123 | 0.240 |
Why?
| | Managed Care Programs | 2 | 2020 | 140 | 0.230 |
Why?
| | Utah | 1 | 2025 | 80 | 0.220 |
Why?
| | Patient Health Questionnaire | 1 | 2025 | 40 | 0.220 |
Why?
| | Adult | 9 | 2025 | 40872 | 0.220 |
Why?
| | Colorado | 2 | 2025 | 4556 | 0.210 |
Why?
| | Sleep | 1 | 2011 | 889 | 0.210 |
Why?
| | Retrospective Studies | 6 | 2025 | 17325 | 0.210 |
Why?
| | Schools, Pharmacy | 1 | 2024 | 48 | 0.210 |
Why?
| | Education, Pharmacy | 1 | 2024 | 120 | 0.180 |
Why?
| | Academic Medical Centers | 1 | 2025 | 554 | 0.180 |
Why?
| | Vitamin K Epoxide Reductases | 1 | 2020 | 12 | 0.160 |
Why?
| | Middle Aged | 7 | 2025 | 36302 | 0.160 |
Why?
| | Cytochrome P-450 CYP2D6 | 1 | 2020 | 32 | 0.160 |
Why?
| | Female | 9 | 2025 | 79035 | 0.150 |
Why?
| | Male | 8 | 2025 | 73003 | 0.140 |
Why?
| | Pharmacogenetics | 1 | 2020 | 175 | 0.140 |
Why?
| | Young Adult | 4 | 2025 | 14251 | 0.140 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 6085 | 0.130 |
Why?
| | Adolescent | 4 | 2025 | 22573 | 0.130 |
Why?
| | Education, Pharmacy, Graduate | 1 | 2017 | 13 | 0.130 |
Why?
| | Aged | 4 | 2025 | 26215 | 0.120 |
Why?
| | Humans | 10 | 2025 | 145763 | 0.120 |
Why?
| | International Classification of Diseases | 1 | 2015 | 150 | 0.100 |
Why?
| | Depressive Disorder | 1 | 2015 | 374 | 0.090 |
Why?
| | Proportional Hazards Models | 2 | 2015 | 1330 | 0.090 |
Why?
| | Databases as Topic | 1 | 2011 | 71 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2019 | 3634 | 0.090 |
Why?
| | Suicide, Attempted | 1 | 2015 | 426 | 0.090 |
Why?
| | Practice Guidelines as Topic | 1 | 2019 | 1582 | 0.090 |
Why?
| | Propensity Score | 1 | 2011 | 377 | 0.070 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2011 | 533 | 0.070 |
Why?
| | Risk | 1 | 2011 | 923 | 0.070 |
Why?
| | Research Design | 1 | 2014 | 1139 | 0.060 |
Why?
| | Risk Factors | 2 | 2011 | 10917 | 0.060 |
Why?
| | Internship and Residency | 1 | 2017 | 1269 | 0.060 |
Why?
| | Risk Assessment | 2 | 2015 | 3752 | 0.060 |
Why?
| | Aged, 80 and over | 2 | 2015 | 8346 | 0.060 |
Why?
| | Prevalence | 1 | 2011 | 2874 | 0.050 |
Why?
| | Age Factors | 1 | 2011 | 3346 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2967 | 0.050 |
Why?
| | Comorbidity | 2 | 2015 | 1662 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3937 | 0.030 |
Why?
| | Citalopram | 1 | 2015 | 32 | 0.030 |
Why?
| | Fluoxetine | 1 | 2015 | 56 | 0.030 |
Why?
| | Quality-Adjusted Life Years | 1 | 2014 | 125 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2014 | 225 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1547 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2014 | 644 | 0.020 |
Why?
| | Child | 1 | 2011 | 22739 | 0.020 |
Why?
| | Logistic Models | 1 | 2015 | 2139 | 0.020 |
Why?
| | Databases, Factual | 1 | 2015 | 1491 | 0.020 |
Why?
|
|
Anderson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|